4) VIACYTE Regenerating Health : ViaCyte Acquires Rights to BetaLogics Assets, Expanding and Extending Industry-Leading Prortfolio for Stem Cell-Derived Approaches to Type l Diabetes. http://viacyte.com/press-releases/viacyte-acquires-betalogics/
2) Bohle A, Muller GA, Wehrmann M, et al : Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 1996 ; 54 : S2-S9